# Effect of L-arginine and Glutamine on Preterm

> **NCT01263041** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 75 (actual)

## Conditions studied

- NEC
- Sepsis

## Interventions

- **DRUG:** Glutamine
- **DRUG:** l-arginine

## Key facts

- **NCT ID:** NCT01263041
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2014-02
- **Final completion:** 2014-03
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2014-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01263041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01263041, "Effect of L-arginine and Glutamine on Preterm". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01263041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*